Table 3 Characteristics of ankylosing spondylitis patients with cardiac conduction abnormalities according to conservative criteria; PQ-interval ≥ 220 ms and/or QRS complex ≥ 120 ms (n = 21)

30

m

8

LAFB

5.76

3.2

3

1

0

38

m

18

AV I

2.99

1.34

1.6

1

0

43

m

14

LBBB

1.95

1.07

1.4

1

0

50

m

27

AV I

5.03

3.45

2.8

1

0

52

m

13

AV I

3.9

2.43

2

1

0

HT

57

m

33

RBBB

AV I

3.4

2.3

3.4

1

0

Valve disease

LAFB

59

m

36

LAFB

1

0.9

5.6

1

0

61

m

34

AV I

1

1

1.8

1

BB*

HT

62

m

38

LAFB

4.65

3.88

3.6

1

(BB)

Valve disease,

CAD

63

m

36

LAFB

1.38

3.69

7.2

1

0

HT

63

m

49

AV I

4.11

4.26

6

1

0

64

m

45

LAFB

0.89

2.36

6.8

1

0

Valve disease

64

m

44

LAFB

2.34

2.53

7

1

(BB)

AF; HT

68

m

39

LAFB

3.44

4.99

4.2

0

0

Valve disease

68

m

42

RBBB

5

4.56

5.6

1

0

Valve disease

HT

71

m

55

LAFB

7.1

8.7

3.4

1

(BB)

HT

74

m

25

LBBB

NA

NA

6

1

(BB)

Valve disease,

heart failure

75

m

52

PM

3.84

6.65

7.2

1

(BB)

Valve disease

HT

77

m

23

LAFB

6.78

7.9

6.8

1

(BB)

Valve disease

HT

46

f

39

AV I

2.73

1.62

2.8

1

0

62

f

46

LAFB

3.57

3.09

3.2

2

0